財經一路發
380 - Ep. 370 - Calmer waters for FDA; Servier, Lilly deals
00:00
00:00
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.
For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
單集
380-
Ep. 370 - Calmer waters for FDA; Servier, Lilly deals
已收聽
379-
Ep. 369 - ASCO advances, China innovation & U.S. science under threat
已收聽
378-
Ep. 368 - ASCO Preview, China Policy, ADC Linkers
已收聽
377-
Ep. 367 - FDA, obesity targets and the rise of DACs
已收聽
376-
